Attached files

file filename
EX-32.1 - CERTIFICATION - Xenetic Biosciences, Inc.xenetic_10x-ex3201.htm
EX-31.2 - CERTIFICATION - Xenetic Biosciences, Inc.xenetic_10x-ex3102.htm
EX-31.1 - CERTIFICATION - Xenetic Biosciences, Inc.xenetic_10x-ex3101.htm
EX-21.1 - SUBSIDIARIES OF REGISTRANT - Xenetic Biosciences, Inc.xenetic_10k-ex2101.htm
EX-10.49 - LETTER AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1049.htm
EX-10.48 - LETTER AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1048.htm
EX-10.47 - SETTLEMENT AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1047.htm
EX-10.46 - RIGHT TO SUBLICENSE AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1046.htm
EX-10.45 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Xenetic Biosciences, Inc.xenetic_10k-ex1045.htm
10-K - FORM 10-K - Xenetic Biosciences, Inc.xenetic_10k-123117.htm

Exhibit 23.1

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

 

 

We consent to the incorporation by reference in the Registration Statement of Xenetic Biosciences, Inc. on Form S-8 [File Nos. 333-222272 and 333-218024] of our report dated March 30, 2018, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Xenetic Biosciences, Inc. as of December 31, 2017 and 2016 and for each of the two years in the period ended December 31, 2017, which report is included in this Annual Report on Form 10-K of Xenetic Biosciences, Inc. for the year ended December 31, 2017.

 

 

/s/ Marcum LLP

 

Marcum LLP

Boston, Massachusetts

March 30, 2018